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Background: One of the characteristics of spinal stenosis is elastin degradation and ﬁ  brosis of the extracellular matrix of the 
ligamentum ﬂ  avum. However, there have been no investigations to determine which biochemical factors cause these histologic 
changes. So we performed the current study to investigate the hypothesis that matrix metalloproteinases (MMPs), which possess 
the ability to cause extracellular matrix remodeling, may play a role as a mediator for this malady in the ligamentum ﬂ  avum. 
Methods: The ligamentum ﬂ  avum specimens were surgically obtained from thirty patients with spinal stenosis, as well as from 30 
control patients with a disc herniation. The extents of ligamentum ﬂ  avum elastin degradation and ﬁ  brosis were graded (grade 0-4) 
with performing hematoxylin-eosin staining and Masson’s trichrome staining, respectively. The localization of MMP-2 (gelatinase), 
MMP-3 (stromelysin) and MMP-13 (collagenase) within the ligamentum ﬂ  avum tissue was determined by immunohistochemistry. 
The expressions of the active forms of MMP-2, MMP-3 and MMP-13 were determined by western blot analysis, and the blots were 
quantiﬁ  ed using an imaging densitometer. The histologic and biochemical results were compared between the two conditions. 
Results: Elastin degradation and ﬁ  brosis of the ligamentum ﬂ  avum were signiﬁ  cantly more severe in the spinal stenosis samples 
than that in the disc herniation samples (3.14 ± 0.50 vs. 0.55 ± 0.60, p < 0.001; 3.10 ± 0.57 vs. 0.76 ± 0.52, p < 0.001, respectively). 
The expressions of the active form of MMPs were identified in all the ligamentum flavums of the spinal stenosis and disc 
herniation patients. The expressions of active MMP-2 and MMP-13 were signiﬁ  cantly higher in the spinal stenosis samples than 
that in the disc herniation samples (both p < 0.05). The expression of active MMP-3 was slightly higher in the spinal stenosis 
samples than that in the disc herniation samples, but the difference was not statistically signiﬁ  cant (p = 0.131). MMP-2, -3, and -13 
were positively stained on the ligamentum ﬂ  avum ﬁ  broblasts.
Conclusions: The current results suggest that the increased expression of active MMPs by the ligamentum ﬂ  avum ﬁ  broblasts 
might be related to the elastin degradation and ﬁ  brosis of the ligamentum ﬂ  avum in the patients who suffer with lumbar spinal 
stenosis.
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The ligamentum flavum is composed of elastin and 
collagen fibers in a 2:1 ratio. The elastin fibers provide 
elasticity to the ligament, while the collagen fi  bers provide 
stiffness and stability. With age, the elastin to collagen 
ratio decreases, and this causes decreased elasticity 82
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and increased stiffness or fibrosis. As these age-related 
degenerative changes progress, the ligamentum flavum 
tissues ultimately become disorganized, which contributes 
to the development of spinal stenosis. Previous studies 
have mainly investigated the histologic changes in the 
ligamentum flavum of spinal stenosis patients and they 
reported that there was degradation of elastin fi  bers, with 
an increase in collagen fibers, fibrosis and calcification 
within the hypertrophied ligamentum flavum tissues.
1-5) 
However, to the best our knowledge, there has been 
no study that has investigated the biochemical factors 
associated with these histologic changes. 
Matrix metalloproteinases (MMPs) are a family 
of over 20 zinc-dependent enzymes that degrade all 
kinds of extracellular matrix components such as elastin, 
collagen and proteoglycans.
6-8) MMPs are responsible 
for the remodeling of connective tissues under normal 
physiologic and pathologic conditions. According to their 
substrate specifi  city, the classic MMPs fall into three main 
groups: collagenases (MMP-1, 8, -13), gelatinases (MMP-
2, -9), and stromelysins (MMP-3, -7, -10). Th   e MMPs are 
constitutively expressed in various types of cells such as 
parenchymal, connective tissue and infl  ammatory cells. Th  e 
activity of MMPs is strictly regulated at the level of synthesis 
and activation and by the interaction with endogenous 
inhibitors under normal physiologic conditions. Increased 
MMP activity can result in several pathologic conditions 
such as arthritis, aneurysm, atherosclerosis, mid-dermal 
elastolysis, Marfan syndrome and intervertebral disc 
degeneration and herniation.
9-15) Th  ese  fi  ndings suggest that 
MMPs might also act as a mediator of elastin degradation 
and fibrosis of the ligamentum flavum, which occurs in 
spinal stenosis.
The purpose of the current study is to determine 
(1) whether the ligamentum flavum of spinal stenosis 
patients has more severe elastin degradation and fi  brosis 
compared to that of patients with disc herniation and (2) 
whether there is an increased expression of MMPs in the 
ligamentum flavum of spinal stenosis patients compared 
to that of disc herniation patients and (3) the source of the 
MMPs within the ligamentum fl  avum tissues. 
METHODS
Thirty ligamentum flavum specimens were obtained 
from 30 patients who had undergone decompressive 
laminectomy for neurogenic claudication, which was 
due to degenerative lumbar spinal stenosis. The patients 
suffering with degenerative spondylolisthesis were not 
included in this study. We tried to obtain the entire layer 
of the central portion of the ligamentum fl  avum, and we 
removed all the epidural fat from the ligamentum fl  avum 
specimens. Half of each specimen was fi  xed in 4% neutral 
formalin, decalcifi  ed with 20% ethylenediaminetetraacetic 
acid (EDTA) for four to six weeks and then embedded in 
paraffi   n for histologic and immunohistochemical analyses; 
the other half was kept in a freezer at –70
oC for subsequent 
western blot analysis. We randomly selected thirty gender-
matched control patients with lumbar disc herniation from 
a group of 234 patients who were operatively managed for 
that disorder. 
Histologic Analysis for Elastin Degradation and 
Fibrosis of the Ligamentum Flavum 
Two consecutive sections (4-μm thick) were cut on a mi-
crotome and these were stained by Masson’s trichrome and 
hematoxylin-eosin stains, respectively. Masson’s trichrome 
stain was used to evaluate the degree of fibrosis and 
hematoxylin-eosin stain was used to evaluate the elastin 
degradation (loss, fragmentation and disorganization). 
Histologic analysis was independently performed by two 
pathologists on 10 randomly selected, high power fields 
(× 400) of each sample. The average of the 20 grades of 
fi  brosis and elastin degradation was used as the fi  nal grade, 
respectively. 
Masson’s trichrome stain
The severity of ligamentum flavum fibrosis was graded 
according to the guidelines presented by Sairyo et al.
16) 
Grade 0 indicates normal tissue showing no fibrotic 
region, grade 1 indicates fibrosis at < 25% of the entire 
area, grade 2 indicates between 25% and 50% fibrosis of 
the entire area, grade 3 indicates between 50% and 75% 
fi  brosis and grade 4 indicates > 75% fi  brosis (Fig. 1). 
Hematoxylin-eosin stain 
Th   e degree of ligamentum fl  avum elastin degradation was 
also graded using the same scoring system as the fi  brosis 
score. Grade 0 indicates normal tissue showing no elastin 
degradation region, grade 1 indicates elastin degradation 
at < 25% of the entire area, grade 2 indicates between 25% 
and 50% elastin degradation, grade 3, between 50% and 
75% and grade 4 > 75% elastin degradation (Fig. 2). 
Immunohistochemical Analysis for the Localization of 
MMP-2, MMP-3 and MMP-13 
Three consecutive sections (4-μm thick) were cut on a 
micro-tome and these were deparaffi   nized in xylene and 
then they were rehydrated in a graded series of alcohol 
solutions. To determine the expressions of MMP-2, MMP-83
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3 and MMP-13, the avidin-biotin-peroxidase complex 
method and a Histostain
TM-plus SP kit (Zymed Laboratory 
Inc., South San Francisco, CA, USA) were used with 
following the manufacturer’s instructions. Purifi  ed rabbit 
polyclonal antibody specifi  c to MMP-2 (Th  ermo  Scientifi  c, 
San Diego, CA, USA), purified goat polyclonal antibody 
specifi  c to MMP-3 (Santa Cruz Biotech, Santa Cruz, CA, 
USA) and purified rabbit polyclonal antibody to MMP-
13 (Thermo Scientific) were used for this study at an 
optimum dilution recommended by the manufacturers. 
The positive controls were also stained according to the 
manufacturer’s recommendation. 
Western Blot Analysis for the Expressions of Active 
MMP-2, MMP-3 and MMP-13 
100 mg of ligamentum flavum tissue was homogenized 
with fetal bovine serum at 3000 rpm (Tissue Tearor/
Biospec products/model 985-370, Bio-Spec Products, 
Racine, WI, USA) and then this was lysed in lysis buff  er. 
Th   e supernatant was obtained following centrifugation at 
1500 rpm at 4
oC for 30 minutes. Quantifi  cation of protein 
was performed according to Bradford’s method with using 
a protein assay kit (Bio-Rad/Cat No. 500-0006, Pierce 
Chemical Company, Rockford, IL, USA) and the reading 
was done at 595 nm by employing a spectrophotometer 
(Ultrospec 3000, Pharmacia Biotech, Cambridge, United 
Kingdom). For all of the analyses for each sample, 30 μg 
of protein were loaded onto a 12% sodium dodecyl sulfate 
(SDS)-polyacrylamide gel. The protein concentration of 
the lysed ligamentum fl  avum tissue was determined with 
Fig. 1. Grading of the ligamentum ﬂ  avum ﬁ  brosis by Masson’s trichrome staining. In the grade 0 samples (A and C), all the area of the ligamentum 
ﬂ  avum was stained a pink color, indicating a normal, non-ﬁ  brotic state. However, in the grade 4 samples (B and D), most of the area was stained a blue 
color, indicating that most of the area was ﬁ  brotic. 84
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using a bicinchoninic acid (BCA) protein assay reagent 
kit (Bio-Rad 500-0006, Pierce Chemical Company, 
Rockford, IL, USA). After electrophoresis, the proteins 
were transferred to a polyvinylidene difluoride (PVDF) 
membrane (Millipore, St. Quentin, Yvelines, France) for 
two hours at 150 V with using a transfer buffer. After 
blocking the nonspecifi  c binding sites overnight with 5% 
non-fat milk phosphate buffer stock-Tween 20 (TPBS), 
the membranes were incubated for two hours at room 
temperature with purified rabbit polyclonal antibody 
specific to MMP-2, purified goat polyclonal antibody 
specifi  c to MMP-3 and purifi  ed rabbit polyclonal antibody 
to MMP-13. Antibody labeling was identified using 
HRP-conjugated secondary antibodies (Amersham Life 
Sciences, Arlington Heights, IL, USA), and the results 
were visualized using enhanced chemiluminescence (ECL) 
(Amersham Life Sciences, Piscataway, NJ, USA). β-actin 
was used as an internal control for protein loading. The 
blots were quantified using an Imaging Densitometer 
GF670 and molecular analysis software (Bio-Rad, SAFC 
Bioscience, Sigma-Aldrich, USA) three times for each 
sample and the average of the three densities was used as 
the final density. The density is presented as the mean ± 
standard deviation (arbitrary units).
 
Statistical Analysis
The Mann-Whitney U test was used to assess the dif-
ference in the degree of ligamentum fl  avum elastin degra-
dation and fibrosis and the density of active MMP-2, 
-3, and -13 between the spinal stenosis samples and the 
disc herniation samples. A p value of less than 0.05 was 
considered statistically signifi  cant. 
Fig. 2. Grading of the ligamentum ﬂ  avum elastin degradation by hematoxylin-eosin staining. In the grade 0 samples (A and C), rich normal elastin ﬁ  bers 
were organized in a strictly parallel order. However, in the grade 4 samples (B and D), the residual scanty elastin ﬁ  vers were fragmented and disorderly. 85
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RESULTS
Demographic Data
Among the 30 patients with spinal stenosis, 23 were 
women and 7 were men. Th   e mean age of the patients at 
the time of surgery was 63.1 years (range, 51 to 77 years), 
and the mean duration of symptoms between onset and 
operation was 13.1 weeks (range, 4 to 29 weeks). The 
mean thickness of the ligamentum flavum, as measured 
on the T1-weighted axial image of the facet joint level of 
the lesion, was 5.4 mm (range, 4.2 to 7.3 mm). Of the 30 
ligamentum flavum specimens, 21 were obtained from 
the L4-L5 level, seven from the L5-S1 level and two from 
the L3-4 level. The mean age of the patients with disc 
herniation was 31.1 years (range, 19 to 41 years). The 
thickness of the ligamentum fl  avum, as measured on the 
T1-weighted axial image of the facet joint level of the 
lesion, was 2.3 mm (range, 1.5 to 3.2 mm). 
Elastin Degradation and Fibrosis of the Ligamentum 
Flavum 
Th   e mean grade of elastin degradation of the ligamentum 
flavum was significantly higher in the stenosis samples 
than that in the disc herniation samples (3.14 ± 0.50 vs. 
0.55 ± 0.60, respectively, p < 0.001). The mean grade of 
ligamentum flavum fibrosis was also significantly higher 
in the stenosis specimens than that in the disc herniation 
samples (3.10 ± 0.57 vs. 0.76 ± 0.52, respectively, p < 0.001). 
Localization of MMP-2, MMP-3 and MMP-13 
Immunohistochemical analysis demonstrated that MMP-
2, MMP-3, and MMP-13 were positively stained on the 
ligamentum fl  avum fi  broblasts of the patients with spinal 
stenosis and disc herniation, respectively (Fig. 3). 
Expressions of MMP-2, MMP-3, and MMP-13 
Western blot analysis demonstrated the expressions of 
Fig. 3. Immunohistochemical analysis demonstrates that MMP-2 (A), 
MMP-3 (B), and MMP-13 (C) were positively stained on the ligamentum 
flavum fibroblasts of the patients with spinal stenosis (original magni-
ﬁ  cation, x 400).86
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active MMP-2, MMP-3, and MMP-13 in the ligamentum 
flavum specimens of the spinal stenosis patients and 
the disc herniation patients (Fig. 4A). The mean density 
(arbitrary units) of active MMP-2 and MMP-13 was 
statistically higher in the spinal stenosis specimens than 
that in the disc herniation specimens (324.75 ± 63.66 
vs. 238.00 ± 76.05, respectively, p < 0.05; 340.00 ± 48.63 
vs. 248.50 ± 52.09, respectively, p < 0.05). Although the 
mean density (arbitrary units) of active MMP-3 was 
slightly higher in the spinal stenosis specimens than that 
in the disc herniation specimens, the difference was not 
statistically signifi  cant (329.24 ± 65.91 vs. 305.24 ± 71.35, 
respectively, p = 0.131) (Fig. 4B).
DISCUSSION
The initial studies on the ligamentum flavum in patients 
with spinal stenosis revealed profound histologic changes, 
including hypertrophy, fi  brosis and loss of elastin. Sairyo 
et al.
16)  examined the ligamentum flavum specimens 
from patients with spinal stenosis or discogenic back pain 
and they were the first to report a positive relationship 
between the thickness of the ligamentum flavum and 
the loss of elasticity and fibrosis. However, one criticism 
of that primary study is that the specimens from the 
two conditions were analyzed as one group that was 
differentiated only by the degree of thickness of the 
ligamentum flavum. We sought to further characterize 
these fi  ndings regarding the ligamentum by comparing the 
degree of elastin degradation and fi  brosis in spinal stenosis 
patients to that of a control group of disc herniation 
patients. 
In addition, we sought to determine which bio  chemi-
cal factors might be responsible for these changes. Recent 
reports have suggested that increased concentrations of 
transforming growth factor-beta 1 (TGF-β1) or tissue in-
hibitors of metalloproteinases (TIMPs) might be associated 
with ligamentum flavum hypertrophy in patients with 
spinal stenosis.
17-20) It is well known that MMPs can 
degrade elastin and collagen components within the var-
ious connective tissues of the body.
6-8) Based on this, we 
hypothesized that MMPs might also play a role on the 
histologic changes that occur in the ligamentum fl  avum of 
spinal stenosis patients. We chose to examine three MMPs: 
MMP-2 (gelatinase), which most prominently possesses 
the ability to degrade elastin; MMP-3 (stromelysin), which 
digests various components of the extracellular matrix like 
proteoglycans, fibronectin, collagen, laminin, gelatin and 
elastin and they can activate other MMPs, and MMP-13 
(collagenase), which is known to be involved in collagen 
degradation. To the best of our knowledge, this is the fi  rst 
study to compare the degree of ligamentum fl  avum elastin 
degradation and fibrosis in spinal stenosis patients as 
compared to that in more normal controls, and to further 
characterize the possible biochemical etiology of those 
changes. 
We found that the mean grades of elastin degradation 
and fibrosis of the ligamentum flavum were statistically 
higher in the spinal stenosis samples than that in the disc 
herniation samples. Th   e thickness of the ligamentum fl  avum 
Fig. 4. Western blot analysis (A) demonstrated the expressions of active MMP-2, MMP-3 and MMP-13 in the ligamentum ﬂ  avum specimens of the 
spinal stenosis and disc herniation patients, and the blots were quantiﬁ  ed using an Imaging Densitometer. (B) Density is presented as the mean ± 
standard deviation (arbitrary units). The mean density of active MMP-2 and MMP-13 was statistically higher in the spinal stenosis samples than that in 
the disc herniation samples (both p < 0.05). Although the mean density of active MMP-3 was slightly higher in the spinal stenosis samples than that in 
the disc herniation samples, the difference was not statistically signiﬁ  cant (p = 0.131). * p < 0.05.87
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tissues was also statistically higher in the spinal stenosis 
samples than that in the disc herniation samples. In addition, 
we found that the expression of MMP-2 was statistically 
higher in the patients with spinal stenosis than it was in 
those patients with disc herniation (p < 0.05). Considering 
the well-known ability of MMP-2 to degrade elastin, its 
high expression in the ligamentum fl  avum of spinal stenosis 
patients suggests that it may be, at least partially, responsible 
for the severe loss and disorganization of the elastin fibers 
observed in that pathological condition. We also found 
that there was a higher expression of MMP-13 in the spinal 
stenosis samples compared with that of the disc herniation 
samples (p < 0.05). Considering the ability of MMP-13 to 
degrade collagen, this result might seem contradictory for a 
condition where the collagen hypertrophies. However, the 
increased collagen fibers in the ligamentum flavum of the 
spinal stenosis samples were due to an increased deposition 
of abnormally disordered collagen fibers, and not normal 
collagen fi  bers. Previous studies have suggested that TGF-β1 
synthesized by the ligamentum fl  avum fi  broblasts increases 
collagen synthesis, resulting in hypertrophy.
17-19) Therefore, 
it is suggested that increased fibrosis of the ligamentum 
fl  avum in spinal stenosis patients is a net result of a series of 
synthesis and destruction of the collagen fi  bers by TGF-β1 
and MMP-13. The MMP-3 expression was slightly higher 
in the patients with spinal stenosis than that in the disc 
herniation patients, but the difference was not statistically 
significant (p = 0.131). It has been reported that MMP-3 
plays a central role in early matrix destruction, whereas it is 
down-regulated in the late stages of matrix destruction.
21,22) 
Considering that the expression pattern of MMP-3 depends 
on the disease stage, it is not unexpected that the expression 
of MMP-3 was not signifi  cantly higher in the spinal stenosis 
ligamentum fl  avum samples with their elastin degradation, 
and fi  brosis is thought to be a chronic or late-stage fi  nding 
of spinal stenosis. Finally, we detected MMP-2, MMP-3 
and MMP-13 immunoreactivities in the cytoplasm of the 
fibroblasts from the ligamentum flavum tissues of both 
conditions, indicating that these MMPs were synthesized in 
these cells. 
The activity of MMPs can be affected by several 
factors, and especially TIMPs. TIMPs bind strongly but 
noncovalently to activated MMPs. TIMPs are co-expressed 
with MMPs and they contribute to the regulation of their 
activity so that increases in the TIMP levels reduce MMP 
activity. However, contradictory results regarding the delicate 
balance between MMPs and TIMPs have been reported 
in several pathologic conditions such as abdominal aortic 
aneurysms, chronic liver injury and osteoarthritis.
23-26) A 
recent study by Park et al.
20) suggested that the increased 
expression of TIMPs in ligamentum flavum fibroblasts 
is associated with its fibrosis and hypertrophy of the 
ligamentum fl  avum in patients suff  ering with spinal stenosis. 
On the basis of that study and the present findings, the 
combined increased expressions of both MMPs and TIMPs 
suggest that the possibility of a vicious cycle whereby the 
presence of denatured extracellular matrix components 
could lead to increased MMP production, which in turn 
could generate more denatured extracellular matrix 
components. Th   e profound destruction of the extracellular 
matrix components in spinal stenosis patients may stimu- 
late a further increased expression of TIMPs. Further 
understanding the expression levels of MMPs and TIMPs 
for the various degrees of elastin degradation, fibrosis, and 
hypertrophy of the ligamentum fl  avum is necessary to defi  ne 
the exact relationship between these factors and the role that 
they play during the various stages of spinal stenosis. 
As with any study, our study had a few shortcomings. 
While we found increases of MMP-2 and MMP-13 in the 
spinal stenosis samples, this does not necessarily mean that 
these factors are either solely or even partially responsible 
for the histologic changes associated with the clinical 
condition. The increases may be associated findings, but 
not necessarily interrelated findings. Nevertheless, given 
the known activities and roles that these enzymes play, 
we believe that it is reasonable to postulate that there 
might be a cause and eff  ect relationship present. Secondly, 
we used control specimens from patients with disc her-
niations and whose average age was 31.1 years, which was 
significantly younger than that for the specimens from 
the patients with spinal stenosis. It would have been ideal 
to have two different controls: age and gender matched 
specimens from patients without stenosis and gender 
matched specimens from late-teenagers. The former 
would eliminate age as an independent variable, since not 
all older patients develop spinal stenosis. It may be that, 
much like atherosclerosis, a genetic predisposition alters 
the biochemical factors that contribute to the pathologic 
condition. Specimens from late-teenagers who are without 
any degenerative changes would allow us to determine 
the true extent of the perturbations that occur in spinal 
stenosis. Unfortunately, both of these ideal controls rarely 
undergo surgical treatment, making it nearly impossible to 
gather enough samples in a timely fashion. Th   us, we fi  nally 
settled on our present controls, which although admittedly 
they are not ideal, we believe they are reasonable and 
adequate to address the questions that we have posed. 
In conclusion, we found an increased expression 
of active MMPs in the ligamentum flavum fibroblasts of 
spinal stenosis patients as compared with those of disc her-88
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niation patients. In addition, there was more severe elastin 
degradation and fi  brosis of the ligamentum fl  avum in the 
spinal stenosis patients than that in the disc herniation pa-
tients. Th   ese results suggest that an increased expression of 
active MMPs by the ligamentum fl  avum fi  broblasts might 
be related to the elastin degradation and fibrosis of the 
ligamentum fl  avum in the patients who suff  er with lumbar 
spinal stenosis. 
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